Andhra CM launches BIOLUMPIVAXIN, world’ s first DIVA marker vaccine for lumpy skin disease
The Chief Minister of Andhra Pradesh, N. Chandrababu Naidu, launched the indigenous Lumpy Skin Disease( LSD) vaccine BIOLUMPIVAXIN ®, developed by Biovet, a subsidiary of Bharat Biotech. BIOLUMPIVAXIN ® which is CDSCO approved, is the world’ s first and safest, Differentiating Infected from Vaccinated Animals( DIVA) marker vaccine, which will help in disease surveillance to protect livestock from Lumpy Skin disease( LSD). The quality, safety, and efficacy have been extensively tested.
GROWiT raises $ 3 million in Series A round led by GVFL
Protective farming Agritech startup GROWiT India has raised $ 3 million in a Series A funding round led by GVFL, with participation from Veloce Opportunities Fund, JITO, We Founder Circle, Sunicon Ventures Fund, Progrowth Ventures and Hyderabad Angels. The funds raised will be directed towards GROWiT’ s aggressive expansion plans, deepening its R & D capabilities, and strengthening its technology infrastructure.
AgriTech
IPL Biologicals expands its product portfolio, launches 6 new products
IPL Biologicals, a leader in India’ s biological agri-input space, has launched its NXG Range( Soluble Products), a portfolio of six innovative biological products with the objective to boost farm productivity and drive sustainability. The products were unveiled at the company’ s annual meeting in Agra. The newly introduced NXG Range includes Subtilin, Viridex, Sporidex, BT-dex, B. E. E Boost, and 360.
BIOVOICENEWS. COM 13